La bourse ferme dans 6 h 49 min
  • CAC 40

    5 541,24
    -49,55 (-0,89 %)
     
  • Euro Stoxx 50

    3 589,04
    -29,31 (-0,81 %)
     
  • Dow Jones

    31 176,01
    -12,37 (-0,04 %)
     
  • EUR/USD

    1,2176
    +0,0003 (+0,02 %)
     
  • Gold future

    1 861,40
    -4,50 (-0,24 %)
     
  • BTC-EUR

    25 812,29
    +754,86 (+3,01 %)
     
  • CMC Crypto 200

    622,08
    +12,09 (+1,98 %)
     
  • Pétrole WTI

    52,29
    -0,84 (-1,58 %)
     
  • DAX

    13 805,79
    -100,88 (-0,73 %)
     
  • FTSE 100

    6 685,22
    -30,20 (-0,45 %)
     
  • Nasdaq

    13 530,92
    0,00 (0,00 %)
     
  • S&P 500

    3 853,07
    +1,22 (+0,03 %)
     
  • Nikkei 225

    28 631,45
    -125,41 (-0,44 %)
     
  • HANG SENG

    29 447,85
    -479,91 (-1,60 %)
     
  • GBP/USD

    1,3667
    -0,0064 (-0,46 %)
     

South and Central America Extracellular Matrix Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Application ; Raw Material, and Country

ReportLinker
·2 min de lecture

The South and Central America extracellular matrix market was valued at US$ 989. 99 thousand in 2019 and is projected to reach US$ 11,708. 44 thousand by 2027; it is expected to grow at a CAGR of 7. 1% from 2020 to 2027.

New York, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "South and Central America Extracellular Matrix Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Application ; Raw Material, and Country" - https://www.reportlinker.com/p06004239/?utm_source=GNW

Increasing incidences of trauma and cardiovascular diseases, and increasing vascular reconstruction procedures are the key factors fueling the market growth.Moreover, increasing role of extracellular matrix in the treatment of cancer is expected to bolster the market growth during the forecast period.

However, the challenges associated with the usage of decellularized extracellular matrix such as , insufficient preservation of vasculature and extracellular matrix composition hinders the growth of the South and Central America extracellular matrix market.Additionally, the COVID-19 outbreak is negatively impacting the overburdened and underfunded healthcare systems of South and Central America.

Hospitals are already overstressed by the treatment of vector?borne diseases and community?acquired infections and high rates of non?communicable diseases (NCDs). Since the onset of the COVID-19, the prevention and treatment of NCDs such as diabetes and its associated complications have been critically affected in the region, as per the Pan American Health Organization (PAHO).
The South and Central America extracellular matrix market is segmented into application, and raw material.Based on application, the market is segmented into vascular repair and reconstruction, dural repair, wound healing, cardiac repair, pericardial repair and soft tissue repair.

The soft tissue repair segment held the largest share of the market in 2019.However, the vascular repair and reconstruction segment is anticipated to register the highest CAGR during the forecast period.

In terms of raw material, the South and Central America extracellular matrix market is segmented into bovine, porcine and other raw material. The porcine segment held the largest share of the market in 2019, and it is also anticipated to register the highest CAGR during 2020-2027.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC),and National Institute of Health (NIH) are a few of the essential primary and secondary sources studied while preparing this report.
Read the full report: https://www.reportlinker.com/p06004239/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001